Study shows mirabegron effective and well tolerated for overactive bladder
New option for patients bothered by antimuscarinic side effects
06-Mar-2013 -
In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with overactive bladder (OAB) compared to those in a placebo group. The ...
hypertension
nocturia
overactive bladder